Top 20 Biopharma Doubles Recruitment and Reduces Screen Failures Across 188 Sites
A top-20 pharmaceutical company conducted a complex Phase III breast cancer study across North America, Europe, and Asia. One CRO leveraged both Advarra Study Startup and Advarra Enroll to execute the study while providing sites with information and support tools to increase engagement.
Download the case study to learn more.
DATE
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour